Marisel Segarra‐Newnham

644 total citations
24 papers, 437 citations indexed

About

Marisel Segarra‐Newnham is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Marisel Segarra‐Newnham has authored 24 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Marisel Segarra‐Newnham's work include Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Hepatitis C virus research (3 papers). Marisel Segarra‐Newnham is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Hepatitis C virus research (3 papers). Marisel Segarra‐Newnham collaborates with scholars based in United States. Marisel Segarra‐Newnham's co-authors include David Parra, John A. Bosso, Michael E. Klepser, Elizabeth D. Hermsen, Michael J. Rybak, Richard H. Drew and Erika J. Ernst and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Annals of Pharmacotherapy and Hospital Pharmacy.

In The Last Decade

Marisel Segarra‐Newnham

21 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marisel Segarra‐Newnham United States 10 132 127 125 58 48 24 437
Evelyne Santana Girão Brazil 12 250 1.9× 59 0.5× 190 1.5× 13 0.2× 45 0.9× 34 548
Teresa Sukiennik Brazil 12 262 2.0× 32 0.3× 246 2.0× 12 0.2× 43 0.9× 16 525
C. Couzigou France 13 141 1.1× 21 0.2× 128 1.0× 17 0.3× 23 0.5× 31 440
Elisa García‐Vázquez Spain 13 315 2.4× 37 0.3× 332 2.7× 12 0.2× 46 1.0× 63 696
R.B.S. Laing United Kingdom 11 170 1.3× 53 0.4× 140 1.1× 5 0.1× 41 0.9× 33 450
Adnan Seyrek Türkiye 14 73 0.6× 145 1.1× 69 0.6× 51 0.9× 9 0.2× 28 453
Sanghamitra Padhi India 12 136 1.0× 55 0.4× 160 1.3× 17 0.3× 16 0.3× 33 508
Jalaluddin Ashraful Haq Bangladesh 15 140 1.1× 25 0.2× 197 1.6× 14 0.2× 18 0.4× 60 571
Venusto H. San Joaquin United States 11 228 1.7× 69 0.5× 139 1.1× 5 0.1× 61 1.3× 26 647
V. Mondain France 15 349 2.6× 44 0.3× 295 2.4× 5 0.1× 45 0.9× 54 705

Countries citing papers authored by Marisel Segarra‐Newnham

Since Specialization
Citations

This map shows the geographic impact of Marisel Segarra‐Newnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisel Segarra‐Newnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisel Segarra‐Newnham more than expected).

Fields of papers citing papers by Marisel Segarra‐Newnham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisel Segarra‐Newnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisel Segarra‐Newnham. The network helps show where Marisel Segarra‐Newnham may publish in the future.

Co-authorship network of co-authors of Marisel Segarra‐Newnham

This figure shows the co-authorship network connecting the top 25 collaborators of Marisel Segarra‐Newnham. A scholar is included among the top collaborators of Marisel Segarra‐Newnham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisel Segarra‐Newnham. Marisel Segarra‐Newnham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Segarra‐Newnham, Marisel, et al.. (2011). Osteoporosis and Vitamin D Deficiency in HIV-Positive Patients. Journal of Pharmacy Technology. 27(6). 251–257. 1 indexed citations
2.
Segarra‐Newnham, Marisel, et al.. (2010). Antibiotic Prophylaxis for Prevention of Spontaneous Bacterial Peritonitis in Patients Without Gastrointestinal Bleeding. Annals of Pharmacotherapy. 44(12). 1946–1954. 8 indexed citations
3.
Ernst, Erika J., Michael E. Klepser, John A. Bosso, et al.. (2009). Recommendations for Training and Certification for Pharmacists Practicing, Mentoring, and Educating in Infectious Diseases Pharmacotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(4). 482–488. 40 indexed citations
4.
Segarra‐Newnham, Marisel, et al.. (2009). Antibiotic Prophylaxis in Acute Necrotizing Pancreatitis Revisited. Annals of Pharmacotherapy. 43(9). 1486–1495. 2 indexed citations
5.
Segarra‐Newnham, Marisel, et al.. (2007). Effectiveness and Hepatotoxicity of Statins in Men Seropositive for Hepatitis C Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(6). 845–851. 27 indexed citations
6.
Segarra‐Newnham, Marisel. (2007). Manifestations, Diagnosis, and Treatment of Strongyloides stercoralis Infection. Annals of Pharmacotherapy. 41(12). 1992–2001. 146 indexed citations
7.
Segarra‐Newnham, Marisel. (2007). Development of a Treatment Algorithm for Staphylococcal Pyoderma in the Emergency Department. Hospital Pharmacy. 42(3). 226–229. 1 indexed citations
8.
Segarra‐Newnham, Marisel, et al.. (2004). Valacyclovir and Postherpetic Neuralgia. Journal of Pharmacy Technology. 20(4). 229–232. 2 indexed citations
9.
Segarra‐Newnham, Marisel, et al.. (2004). Antibiotic Lock Technique: A Review of the Literature. Annals of Pharmacotherapy. 39(2). 311–318. 61 indexed citations
10.
Segarra‐Newnham, Marisel, et al.. (2004). Probable Vancomycin-Induced Neutropenia. Annals of Pharmacotherapy. 38(11). 1855–1859. 24 indexed citations
11.
Segarra‐Newnham, Marisel. (2004). Treating Veterans for Helicobacter Pylori Infection: Retrospective Evaluation of Long-term Outcomes. Hospital Pharmacy. 39(12). 1165–1169. 1 indexed citations
12.
Segarra‐Newnham, Marisel. (2003). Tracking Vaccination Rates among HIV-Positive Patients with a Computerized Reminder System. Hospital Pharmacy. 38(8). 758–762.
13.
Segarra‐Newnham, Marisel, et al.. (2002). Valganciclovir: A New Oral Alternative for Cytomegalovirus Retinitis in Human Immunodeficiency Virus‐Seropositive Individuals. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1124–1128. 11 indexed citations
14.
Segarra‐Newnham, Marisel. (2002). Hyperlipidemia in HIV-Positive Patients Receiving Antiretrovirals. Annals of Pharmacotherapy. 36. 592–595. 1 indexed citations
15.
Segarra‐Newnham, Marisel. (2002). Hyperlipidemia in HIV-Positive Patients Receiving Antiretrovirals. Annals of Pharmacotherapy. 36(4). 592–595. 7 indexed citations
16.
Segarra‐Newnham, Marisel, et al.. (2001). Use of Cidofovir in Progressive Multifocal Leukoencephalopathy. Annals of Pharmacotherapy. 35. 741–744. 1 indexed citations
17.
Segarra‐Newnham, Marisel, et al.. (2001). Use of Cidofovir in Progressive Multifocal Leukoencephalopathy. Annals of Pharmacotherapy. 35(6). 741–744. 25 indexed citations
18.
Segarra‐Newnham, Marisel. (1999). Use of Large-Dose Gentamicin Regimens in Elderly Men. Hospital Pharmacy. 34(4). 420–422. 2 indexed citations
19.
Segarra‐Newnham, Marisel. (1999). Evaluation of an Electronic Mail System for Communication of Resistant Organisms in a Medical Center. 4(3). 1–7. 2 indexed citations
20.
Segarra‐Newnham, Marisel, et al.. (1998). Antibiotic Prophylaxis in Acute Necrotizing Pancreatitis. Journal of Pharmacy Technology. 14(6). 245–248. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelyne Santana Girão Breakdown of academic impact, for papers by Teresa Sukiennik Breakdown of academic impact, for papers by C. Couzigou Breakdown of academic impact, for papers by Elisa García‐Vázquez Breakdown of academic impact, for papers by R.B.S. Laing Breakdown of academic impact, for papers by Adnan Seyrek Breakdown of academic impact, for papers by Sanghamitra Padhi Breakdown of academic impact, for papers by Jalaluddin Ashraful Haq Breakdown of academic impact, for papers by Venusto H. San Joaquin Breakdown of academic impact, for papers by V. Mondain
Rankless by CCL
2026